GlassScriptPhysician profile
Alexander Shinn
NPI 1730706425
$701.65
in general payments reported to CMS, 2019-2025
10 companies · $464 in 2025
The $464 reported for 2025 was more than what 89% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $30.79 · 2024: $207 · 2025: $464.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $582 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $582.14 |
| Education | $119.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $160.62 | 2024-2025 | Camzyos |
| Medtronic, INC. | $119.51 | 2025 | Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Abiomed | $116.01 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $97.87 | 2023-2025 | Lifevest |
| Amgen INC. | $90.49 | 2024 | Repatha |
| Edwards Lifesciences Corporation | $51.92 | 2024-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Bayer Healthcare Pharmaceuticals INC. | $19.23 | 2025 | |
| Janssen Pharmaceuticals, INC | $17.23 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $15.24 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $13.53 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Shinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.